See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Laird Superfood, Inc. (LSF) - free report >>
Similarweb Ltd. (SMWB) - free report >>
Nuvectis Pharma, Inc. (NVCT) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Laird Superfood, Inc. (LSF) - free report >>
Similarweb Ltd. (SMWB) - free report >>
Nuvectis Pharma, Inc. (NVCT) - free report >>
Image: Bigstock
New Strong Buy Stocks for July 10th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Corebridge Financial, Inc. (CRBG - Free Report) : This company which provides retirement solutions and insurance products has seen the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.
Corebridge Financial, Inc. Price and Consensus
Corebridge Financial, Inc. price-consensus-chart | Corebridge Financial, Inc. Quote
Laird Superfood, Inc. (LSF - Free Report) : This producer of plant-based foods has seen the Zacks Consensus Estimate for its current year earnings increasing 8.3% over the last 60 days.
Laird Superfood, Inc. Price and Consensus
Laird Superfood, Inc. price-consensus-chart | Laird Superfood, Inc. Quote
Similarweb Ltd. (SMWB - Free Report) : This company that provides a platform for digital intelligence has seen the Zacks Consensus Estimate for its current year earnings increasing 38.6% over the last 60 days.
Similarweb Ltd. Price and Consensus
Similarweb Ltd. price-consensus-chart | Similarweb Ltd. Quote
Nuvectis Pharma, Inc. (NVCT - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 32% over the last 60 days.
Nuvectis Pharma, Inc. Price and Consensus
Nuvectis Pharma, Inc. price-consensus-chart | Nuvectis Pharma, Inc. Quote
WisdomTree, Inc. (WT - Free Report) : This company that offer a well-diversified suite of exchange-traded products, models and solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 9.4% over the last 60 days.
WisdomTree, Inc. Price and Consensus
WisdomTree, Inc. price-consensus-chart | WisdomTree, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.